programmed cell death-1 (PD-1) antibody, nivolumab, has been widely used as an ICI. ICIs have a unique adverse event known as immunerelated adverse event (irAE) which manifest most frequently as a skin disorder, and very rarely as a renal disorder.
than that of other organ dysfunction, patients may develop severe AKI requiring haemodialysis. ICIs induced-AKI is characterized by late onset after administration, and in our case, it was the longest duration among the reported cases. It is speculated that ICIs re-program the immune system, leading to the loss of tolerance to endogenous and exogenous antigens, which is different from the mechanism underlying AKI induced by other medications. Therefore, re-challenging ICIs after recovery of the renal function should be tried. Nevertheless, prolonged follow up is needed to detect the late recurrence of severe AKI as reported in our case. Background and Aims: Lung cancer is one of world's deadliest cancer, with 1.8 million new cases and 1.59 million deaths caused by lung cancer in 2012. Lung cancer is also known to be more prevalent in males than in females. Although active smoking is already known to have causative relationship with lung cancer, about 25% of lung cancer cases worldwide are not associated with active smoking. In Southeast Asia, approximately 50% of lung cancer cases are thought to have nothing to do with active smoking.
Methods: This study is a case-control study with 45 subjects in total: 27 with lung cancer and 18 with no lung cancer who enrolled to Persahabatan National Hospital in July 2016 -January 2017. The data regarding demographics, smoking status, exposure to environmental tobacco smoke, family history of cancer, history of tuberculosis, and exposure to indoor air pollution of each patient were obtained. Descriptive statistics, Chi square hypothesis test, and logistic regression hypothesis test were used for analysis.
Results:
Results from bivariate analysis showed that environmental tobacco smoke (ETS) (OR = 6.914; 853 ) and family history of cancer (OR = 8.5; CI 0.971-74.424) were associated with increased risk of lung cancer in male never-smokers, while other risk factors were not found to have been associated with lung cancer in male never-smokers. Multivariate analysis showed both ETS and family history of lung cancer were associated with risk of lung cancer in male never-smokers, with ETS being the most associated factor having individuals with exposure to ETS to have 8,479 more likely odds of developing lung cancer.
Conclusion:
There is a significant association between exposure to environmental tobacco smoke (ETS) and family history of cancer with increased risk of lung cancer in male never-smokers, with ETS being the most associated factor with the increased odds of developing lung cancer in male never-smokers. 
Methods:
The patient was a 64-year-old woman who was found to have right lung segment S4 ground-glass nodule (GGN) on chest computed tomography (CT) following opacification detected on routine chest X-ray. Follow-up CT revealed a 42-mm GGN nodule with a 26-mm nodule (S6) and a 20-mm GGN (S10).
Results: Histopathology of resected specimens from the right middle and lower lobes revealed all three nodules were adenocarcinoma. Four EGFR mutations were detected; no three tumours had the same mutations. Background and Aims: Mycoplasm pneumoniae is the main pathogen in upper respiratory tract infection among children, and the morbidity is also high. In addition to causing respiratory mucosa, it can act as an allergen to cause airway hyperresponsiveness, result in long-range cough, even trigger or develop asthma. Leukotriene receptor antagonist montelukast can block Mycoplasma pheumoniae that stimulates the inflammatory response of the repiratory tract as an allergen after infection, and lower airwy hyperresponsiveness Methods: Totally 100 children infected with Mycoplasma pneumoniae from June 2015 to June 2016 in paediatrics department of our hospital were selected to randomly assign into the observation group and the control group. Both groups took conventional anti-mycoplasma therapy, pneumoniae that stimulates the inflammatory response of the respiratory tract as an allergen after infection, lower airway hyperresponsiveness, reduce mucus secretion, ease bronchial spasm, and shorten the duration of cough.
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This abstract has been withdrawn. Methods: Case-A 6-year-old girl was referred to our unit for persistent right lung collapse. She presented with history of cough and exertion dyspnea for 2 months. She was treated as necrotizing pneumonia and after 3 weeks of antibiotics; she had minimal clinical improvement and chest X-ray showed persistent right lung collapse. Examination showed she was tachypnoeic with reduced chest expansion and breath sounds on the right lung. Otherwise no crepitation or rhonchi was heard.
Investigations-She was investigated extensively, including pulmonary tuberculosis and it was negative. Ultrasound thorax and CECT thorax showed collapsed consolidation consistent with necrotizing pneumonia and nodular like echogenic lesion in a consolidated lung parenchyma. Bronchoscopy revealed intraluminal vascularized mass at right main bronchus causing almost complete obstruction.
Results: Managements -Excision biopsy was done with intraoperative finding of large vascularized mass from right main bronchus extending to the right upper lobe with multiple irregular nodules. Histopathology reported as Large Cell Neuroendocrine Carcinoma. In view of no standard guideline of chemotherapy in this type of carcinoma, she was treated as rhabdomyosarcoma-like tumour with vincristine, ifosfomide, doxorubicin and actinomycin. She underwent right thoracotomy and gross tumour excision after 2 cycles of chemotherapy. The tumour was excised as much as possible however residual tumour was still seen encircling the trachea, hoping that it will shrink further with subsequent cycle of chemotherapy.
Conclusion: Large Cell Neuroendocrine Carcinoma is a rare primary endobronchial tumour and no standard therapy yet known to treat the condition. University of Indonesia-Persahabatan General Hospital, Indonesia Background and Aims: Massive haemoptysis is defined as blood loss more than 200 mL per day, rare but potentially life threatening in children. Acute lower respiratory infection and foreign body aspiration are the most common cause of haemoptysis in children. Pulmonary sequestration (PS) is a rare congenital bronchopulmonary malformation accounting for 0.15%-6.4% of all congenital pulmonary malformations that can be classified into intralobar sequestration (ILS) and extralobar sequestration (ELS). Its receive blood supply from systemic circulation arteries (mainly thoracic aorta and aorta abdominalis). ILS is the most common type (75-85%). Main manifestations of PS are recurrent respiratory tract infection. Haemoptysis is not a common symptom in PS.
Methods: Eight years old male child came to emergency department with massive haemoptysis (>400 mL in 24 h), with chest X-ray showing an opacity in the right lower lobe. This patient has a history of haemoptysis 10 months before and treated with antituberculosis drug but no improvement. We performed a flexible bronchoscopy to identify the source of bleeding.
Results: We found an active bleeding from the right lower lobe. We also found a multiloculated infiltration mass like polyp in right lower lobe and left lower lobe. CT angiography was done which demonstrated an intralobar pulmonary sequestration in the right and left lower lobes that provide arterial blood supply from thoracic aorta, vertebra artery and pulmonary artery.
Conclusion:
We demonstrated a case of the lung sequestration in male children. Massive haemoptysis is not common symptom in pulmonary sequestration. Congenital pulmonary sequestration is a rare lung malformation. In cases of recurrent pulmonary infections of identical localization or recurrent haemoptysis, lung sequestration should be considered in children so that a diagnosis by imaging methods can be confirmed rapidly. The fact that using flexible bronchoscopy can find the source of bleeding and the abnormality of the airway. This case report aims to discuss a case of a 1-month old male who presented with persistent respiratory distress since birth.
Methods:
The patient was born to a 36 y/o G3P2 (3012) mother, full term, via repeat CS. At birth, the patient was noted to be tachypneic. Clear breath sounds is appreciated on the left with decreased breath sounds on the right. CT scan showed intralobar sequestration of the right lower lobe with adjacent cysts to consider CPAM type 2. Right lower lobe lobectomy was done which showed large arterial branch from the aorta connected to the right lower lobe, with right lower lobe consolidation and cystic areas. Final histopathology result showed CPAM type II.
Results: Pulmonary sequestration consists of 2 types. Intralobar sequestration is usually found in the posterior basal segment of the left lower lobe encircled by visceral pleura without pleural separation from the rest of the lobe. Symptoms in neonates and infants are uncommon. It affects males four times more frequently than females. In both types, the pulmonary tissue is largely cystic and contains disorganized, airless alveoli, bronchi, cartilage, respiratory epithelium, and a systemic artery. It is often secondarily infected, bronchiectatic, or atelectatic, and may show histology of a CCAM, particularly type 2 CCAM in extralobar variants.
